On 11/19/24, Lifecore Biomedical Inc (NASDAQ: LFCR) stock enjoyed a major increase of 10.3%, closing at $7.09. Moreover, this advance was accompanied by above average trading volume at 149% of normal. Relative to the market the stock has been weak over the last nine months but has risen 8.4% during the last week.
Current PriceTarget Research Rating
Lifecore Biomedical has a current Value Trend Rating of F (Lowest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Lifecore Biomedical has a slightly negative Power Rating of 37 and a very low Appreciation Score of 1, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment